{"nct_id":"NCT00220402","title":"Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome","status":"COMPLETED","status_verified_date":"2008-11","start_date":"2004-07","start_date_type":null,"primary_completion_date":"2007-07","primary_completion_date_type":"ACTUAL","completion_date":"2007-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}